IL13 and lung disorder: While the role of CD2 in human lung disease remains largely unknown, our data are the first to demonstrate that genetic ablation of CD2 in mice results in significant reduction in AHR, lung inflammation and goblet cell hyperplasia that is specifically associated with the expression of IL-13 and its receptors.